Amprenavir
- TRADE NAME: Agenerase (GSK)
- INDICATIONS: HIV infection
- CLASS: Antiretroviral, HIV-1 protease inhibitor
- HALF-LIFE: 7–11 hours
Alprazolam, Amiodarone, Amitriptyline, Amlodipine, Amoxapine, Antacids, Atorvastatin, Avanafil, Benzodiazepines, Bepridil, Bosentan, Carbamazepine, Cisapride, Clomipramine, Clonazepam, Clorazepate, Cyclosporine, Delavirdine, Desipramine, Dexamethasone, Diazepam, Didanosine, Dihydroergotamine, Diltiazem, Doxepin, Efavirenz, Ergotamine, Estradiol, Felodipine, Fentanyl, Flibanserin, Flurazepam, Fluticasone Propionate, Imipramine, Indinavir, Isradipine, Itraconazole, Ixabepilone, Ketoconazole, Lidocaine, Lopinavir, Lorazepam, Lovastatin, Lumateperone, Methadone, Methylergonovine, Methysergide, Midazolam, Mifepristone, Nelfinavir, Nevirapine, Nicardipine, Nifedipine, Nimodipine, Nisoldipine, Nortriptyline, Olaparib, Oral Contraceptives, Oxazepam, Phenobarbital, Phenytoin, Pimozide, Protriptyline, Quazepam, Quinidine, Rapamycin, Rifabutin, Rifampin, Ritonavir, Saquinavir, Sildenafil, Simvastatin, St John's Wort, Tacrolimus, Temazepam, Trazodone, Triazolam, Tricyclic antidepressants, Trimipramine, Verapamil, Vitamin E, Warfarin
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
